Quality assurance in intensive care medicine. SARI - Surveillance on antibiotic use and bacterial resistance in intensive care units;Qualitätssicherung in der intensivmedizin. SARI - Surveillance der Antibiotikaanwendung und bakteriellen Resistenzentwicklung auf Intensivstationen

Anaesthesist

Volumn 53, Issue 5, 2004, Pages 427-433

  Meyer, E ^a   Schroeren Boersch, B ^a   Schwab, F ^b,d   Jonas, D ^a   Ruden H ^b,d   Gastmeier, P ^c,d   Daschner, F D ^a,d  

^a UNIVERSITY OF FREIBURG   (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^c HANNOVER MEDICAL SCHOOL   (Germany)

^d Medizinische Hochschule Hannover ^*  (Germany)

Author keywords

Antibiotic use; Intensive care units; Resistance rates; SARI; Surveillance

Indexed keywords

AMPICILLIN; ANTIINFECTIVE AGENT; CEFOTAXIME; CEFTAZIDIME; CEFTRIAXONE; CIPROFLOXACIN; ERYTHROMYCIN; IMIPENEM; OXACILLIN; PIPERACILLIN; SULBACTAM; TAZOBACTAM; VANCOMYCIN;

ANTIBIOTIC PROPHYLAXIS; ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL INFECTION; BACTERIAL TRANSMISSION; CORRELATION ANALYSIS; DATA ANALYSIS; GERMANY; HEALTH SURVEY; HOSPITAL MANAGEMENT; HUMAN; INFECTION CONTROL; INFECTION RISK; INTENSIVE CARE UNIT; QUALITY CONTROL; RISK FACTOR;

ANTI-BACTERIAL AGENTS; BACTERIAL INFECTIONS; DATA INTERPRETATION, STATISTICAL; DRUG RESISTANCE, BACTERIAL; DRUG UTILIZATION; GENOTYPE; GERMANY; HUMANS; INTENSIVE CARE; INTENSIVE CARE UNITS; LABORATORIES, HOSPITAL; POPULATION SURVEILLANCE; QUALITY ASSURANCE, HEALTH CARE;

EID: 2942571220     PISSN: 00032417     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00101-004-0668-2     Document Type: Article

References (9)

1. Archibald L, Phillips L, Monnet D, McGowan JE Jr, Tenover F, Gaynes R (1997) Antimicrobial resistance in isolates from inpatients and outpatients in the United States: increasing importance of the intensive care unit. Clin Infect Dis 24:211-215
2. Fridkin SK, Steward CD, Edwards JR et al. (1999) Surveillance of antimicrobial use and antimicrobial resistance in United States hospitals: project ICARE phase 2. Project Intensive Care Antimicrobial Resistance Epidemiology (ICARE) hospitals. Clin Infect Dis 29:245-252
3. Geffers C, Koch J, Sohr D, Nassauer A, Daschner F, Rüden H, Gastmeier P (2000) Aufbau einer Referenzdatenbank für nosokomiale Infektionen auf Intensivstationen. Erste Ergebnisse des nationalen Krankenhaus-Infektions-Surveillance-Systems (KISS). Anästhesist 49:732-737
4. Kresken M, Hafner D (2000) Resistenzsituation bei klinisch wichtigen Infektionserregern gegenüber Chemotherapeutika in Mitteleuropa. Chemother J 9:51-86
5. Kresken M, Hafner D, Schmitz F, Wichelhaus T (2003) Resistenzsituation bei klinisch wichtigen Infektionserregern gegenüber Antibiotika in Deutschland und im mitteleuropäischen Raum. In: PEG-Resistenzstudie. Gesellschaft für klinisch-mikrobiologische Forschung und Kommunikation mbH Bonn, S 1-86
6. Meyer E, Jonas D, Schwab F, Rueden H, Gastmeier P, Daschner FD (2003) Design of a surveillance system of antibiotic use and bacterial resistance in German intensive care units (SARI). Infection 31:93-100
7. Monnet DL, Sorensen TL (1999) Interpreting the effectiveness of a national antibiotic policy and comparing antimicrobial use between countries. J Hosp Infect 43:239-242
8. Monnet DL, Archibald LK, Phillips L, Tenover FC, McGowan JE Jr, Gaynes RP (1998) Antimicrobial use and resistance in eight US hospitals: complexities of analysis and modeling. Intensive Care Antimicrobial Resistance Epidemiology Project and National Nosocomial Infections Surveillance System Hospitals. Infect Control Hosp Epidemiol 19:388-394
9. NNIS (2002) National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 to June 2002. Am J Infect Control 30:458-475